Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Regeneron Pharmaceuticals Inc. (REGN)

381.17 2.66 (0.7%)

12-14 16:00

Open:

382.96

Pre. Close:

378.51

High:

386.9

Low:

379

Volume:

756,951

Market Cap:

41214M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

387.364 - 388.854

388.854 - 390.343

Low:

375.058 - 376.859

376.859 - 378.659

Close:

378.3 - 381.025

381.025 - 383.751

Technical analysis  (as of: 2018-12-14 4:27:16 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 462.90     One year: 540.67

Support:

Support1: 356.29    Support2: 331.54

Resistance:

Resistance1: 396.32    Resistance2: 462.90

Pivot:

369.16

Moving Averages:

MA(5): 378.19     MA(20): 362.19

MA(100): 375.83     MA(250): 352.42

MACD:

MACD(12,26): 5.95     Signal(12,26,9): 3.36

%K %D:

%K(14,3): 71.20     %D(3): 70.36

RSI:

RSI(14): 60.12

52-Week:

High: 416.49  Low: 281.89  Change(%): -2.0

Average Vol(K):

3-Month: 74008  10-Days 79566

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
REGN has closed below upper band by 25.3%. Bollinger Bands are 12.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-12-14T08:48:20-05:00
Goldman bearish on Walgreens Boots Alliance in premarket analyst action; shares down 4% premarket

2018-12-14T07:37:00-05:00
Stocks making the biggest moves premarket: COST, ADBE, SBUX, AAPL & more

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

108.23

Shares Float (M)

106.73

% Held by Insiders

1.40

% Held by Institutions

109.40

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

18.240

EPS Est. Current Year

14.940

EPS Est. Next Year

16.370

EPS Est. Next Quarter

3.980

Forward EPS

20.923

Book Value (p.s.)

5.250

PEG Ratio

1.49

Profit Margin

30.24

Operating Margin

37.00

Return on Assets (ttm)

18.4

Return on Equity (ttm)

25.8

Qtrly Rev. Growth

10.8

Gross Profit (p.s.)

13.644

Sales Per Share

EBITDA (p.s.)

5.519

Qtrly Earnings Growth

53.10

Operating Cash Flow (M)

2030.00

Levered Free Cash Flow (M)

1130.00

Valuation

P/E

20.90

P/E Growth Ratio

0.01

P/BV

72.60

P/S

684546240.00

P/CF

20.32

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.